This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, C.-T. Articles by Carbone, D. P. Search for Related Content PubMed PubMed Citation Articles by Lee, C.-T. Articles by Carbone, D. P.

Combination Therapy with Conditionally Replicating Adenovirus and Replication Defective Adenovirus

¹ Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee; ² Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Lung Institute of Medical Research Center, Seoul National University College of Medicine and Respiratory Center, Seoul National University Bundang Hospital, Seongnam, Korea; and ³ Gene Therapy Center, University of Alabama at Birmingham, Birmingham, Alabama

Low gene transfer rate is the most substantial hurdle in the practical application of gene therapy. One strategy to improve transfer efficiency is the use of a conditionally replicating adenovirus (CRAD) that can selectively replicate in tumor cells. We hypothesized that conventional E1-deleted adenoviruses (ad) can become replication-competent when cotransduced with a CRAD to selectively supply E1 in trans in tumors. The resulting selective production of large numbers of the E1-deleted ad within the tumor mass will increase the transduction efficiency. We used a CRAD (24RGD) that produces a mutant E1 without the ability to bind retinoblastoma but retaining viral replication competence in cancer cells with a defective pRb/p16. Ad-lacZ, adenovirus-luciferase (ad-luc), and adenovirus insulin-like growth factor-1R/dominant-negative (ad-IGF-1R/dn; 482, 950) are E1-deleted replication-defective adenoviruses. The combination of CRAD and ad-lacZ increased the transduction efficiency of lacZ to 100% from 15% observed with ad-lacZ alone. Transfer of media of CRAD and ad-lacZ cotransduced cells induced the transfer of lacZ (media transferable bystander effect). Combination of CRAD and ad-IGF-1R/dn increased the production of truncated IGF-1R or soluble IGF-1R > 10 times compared with transduction with ad-IGF-1R/dn alone. Combined intratumoral injection of CRAD and ad-luc increased the luciferase expression about 70 times compared with ad-luc alone without substantial systemic spread. Combined intratumoral injection of CRAD and ad-IGF-1R/482 induced stronger growth suppression of established lung cancer xenografts than single injections. The combination of CRAD and E1-deleted ad induced tumor-specific replication of CRAD and E1-deleted ad and increased the transduction rate and therapeutic efficacy of these viruses in model tumors.

This article has been cited by other articles:

				H.-J. Lee, Y.-J. Lee, H.-C. Kwon, S. Bae, S.-H. Kim, J.-J. Min, C.-K. Cho, and Y.-S. Lee Radioprotective Effect of Heat Shock Protein 25 on Submandibular Glands of Rats Am. J. Pathol., November 1, 2006; 169(5): 1601 - 1611. [Abstract] [Full Text] [PDF]

				D. Hoffmann and O. Wildner Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy. Mol. Cancer Ther., August 1, 2006; 5(8): 2013 - 2022. [Abstract] [Full Text] [PDF]

				T. D. McKee, P. Grandi, W. Mok, G. Alexandrakis, N. Insin, J. P. Zimmer, M. G. Bawendi, Y. Boucher, X. O. Breakefield, and R. K. Jain Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. Cancer Res., March 1, 2006; 66(5): 2509 - 2513. [Abstract] [Full Text] [PDF]

				X. Li, S. P. Raikwar, Y.-H. Liu, S.-J. Lee, Y.-P. Zhang, S. Zhang, L. Cheng, S.-D. Lee, B. E. Juliar, T. A. Gardner, et al. Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene. Mol. Cancer Ther., March 1, 2006; 5(3): 676 - 684. [Abstract] [Full Text] [PDF]

				C.-T. Lee, Y.-J. Lee, S.-Y. Kwon, J. Lee, K. I. Kim, K.-H. Park, J. H. Kang, C.-G. Yoo, Y. W. Kim, S. K. Han, et al. In vivo Imaging of Adenovirus Transduction and Enhanced Therapeutic Efficacy of Combination Therapy with Conditionally Replicating Adenovirus and Adenovirus-p27 Cancer Res., January 1, 2006; 66(1): 372 - 377. [Abstract] [Full Text] [PDF]